X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ASTRAZENECA PHARMA FDC LTD./
ASTRAZENECA PHARMA
 
P/E (TTM) x 17.5 93.7 18.7% View Chart
P/BV x 3.6 13.3 27.3% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 FDC LTD.   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ASTRAZENECA PHARMA
Mar-14
FDC LTD./
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,285 11.2%   
Low Rs79634 12.5%   
Sales per share (Unadj.) Rs47.6189.6 25.1%  
Earnings per share (Unadj.) Rs7.6-0.2 -3,737.3%  
Cash flow per share (Unadj.) Rs9.03.8 234.4%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.568.6 69.3%  
Shares outstanding (eoy) m177.8325.00 711.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.35.1 46.2%   
Avg P/E ratio x14.6-4,712.7 -0.3%  
P/CF ratio (eoy) x12.3249.6 4.9%  
Price / Book Value ratio x2.314.0 16.7%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,78423,988 82.5%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m1,2211,605 76.1%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m8,4594,740 178.5%  
Other income Rs m39492 427.3%   
Total revenues Rs m8,8524,832 183.2%   
Gross profit Rs m2,070-130 -1,594.9%  
Depreciation Rs m249101 246.1%   
Interest Rs m310-   
Profit before tax Rs m2,184-139 -1,572.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m6065 11,896.9%   
Profit after tax Rs m1,353-5 -26,584.5%  
Gross profit margin %24.5-2.7 -893.7%  
Effective tax rate %27.7-3.7 -756.8%   
Net profit margin %16.0-0.1 -14,896.6%  
BALANCE SHEET DATA
Current assets Rs m4,3552,726 159.7%   
Current liabilities Rs m1,7922,435 73.6%   
Net working cap to sales %30.36.1 492.9%  
Current ratio x2.41.1 217.1%  
Inventory Days Days4474 60.3%  
Debtors Days Days2541 60.5%  
Net fixed assets Rs m3,0251,035 292.2%   
Share capital Rs m17950 357.2%   
"Free" reserves Rs m8,243942 874.6%   
Net worth Rs m8,4531,716 492.6%   
Long term debt Rs m110-   
Total assets Rs m10,5574,156 254.0%  
Interest coverage x71.4NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.81.1 70.3%   
Return on assets %13.1-0.1 -10,705.4%  
Return on equity %16.0-0.3 -5,396.8%  
Return on capital %23.50-  
Exports to sales %13.35.7 233.5%   
Imports to sales %3.36.5 51.7%   
Exports (fob) Rs m1,126270 416.6%   
Imports (cif) Rs m283306 92.3%   
Fx inflow Rs m1,146375 306.0%   
Fx outflow Rs m355470 75.6%   
Net fx Rs m791-96 -827.6%   
CASH FLOW
From Operations Rs m1,485-8 -18,332.1%  
From Investments Rs m-620-146 425.2%  
From Financial Activity Rs m-753862 -87.3%  
Net Cashflow Rs m113709 15.9%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.7 0.3 1,566.7%  
FIIs % 7.5 15.7 47.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 9.1 208.8%  
Shareholders   23,730 12,856 184.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   MERCK LTD  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 18, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - SUVEN LIFE COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS